1. Home
  2. OSRH vs ICU Comparison

OSRH vs ICU Comparison

Compare OSRH & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OSR Holdings Inc.

OSRH

OSR Holdings Inc.

HOLD

Current Price

$0.63

Market Cap

18.4M

Sector

N/A

ML Signal

HOLD

Logo SeaStar Medical Holding Corporation

ICU

SeaStar Medical Holding Corporation

HOLD

Current Price

$2.40

Market Cap

15.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSRH
ICU
Founded
N/A
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.4M
15.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OSRH
ICU
Price
$0.63
$2.40
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.9M
141.1K
Earning Date
02-24-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$881,000.00
Revenue This Year
N/A
$691.85
Revenue Next Year
N/A
$64.17
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1195.59
52 Week Low
$0.45
$2.20
52 Week High
$11.84
$30.70

Technical Indicators

Market Signals
Indicator
OSRH
ICU
Relative Strength Index (RSI) 46.39 63.95
Support Level $0.69 $2.26
Resistance Level $0.84 $2.71
Average True Range (ATR) 0.09 0.23
MACD -0.00 -0.05
Stochastic Oscillator 21.00 20.41

Price Performance

Historical Comparison
OSRH
ICU

About OSRH OSR Holdings Inc.

OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.

About ICU SeaStar Medical Holding Corporation

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

Share on Social Networks: